CELLFORCURE
CellforCure is a key industrial and innovative player in the field of advanced therapy medicinal products.
CELLFORCURE
Social Links:
Industry:
Biotechnology Health Care
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.cellforcure.com
Total Employee:
101+
Status:
Active
Contact:
33 (0) 1 69 82 17 21
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare Hosting Proofpoint CodeTwo Akamai DNS
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Current Employees Featured
Official Site Inspections
http://www.cellforcure.com
- Host name: 104.18.0.16
- IP address: 104.18.0.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CellforCure"
CellforCure - Crunchbase Company Profile & Funding
Organization. CellforCure . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CellforCure is a key industrial and innovative player in the …See details»
CELLforCURE - Overview, News & Similar companies - ZoomInfo
Dec 20, 2018 CELLforCURE is a pharmaceutical company, and has been a pharmaceutical establishment since 2013, acting as a CDMO (Contract Development and Manufac turing …See details»
CELLforCURE - Products, Competitors, Financials, Employees ...
May 10, 2021 CellforCure is a French-based contract development and manufacturing organization (CDMO) that provides a manufacturing facility for cell and gene therapy. The …See details»
Seqens acquires Novartis’s cell therapy business in France
Dec 17, 2023 CellforCure, located in Les Ulis, near Paris, was launched in 2013 by LBF (Laboratoire français du Fractionnement et des Biotechnologies) and acquired by Novartis in …See details»
Cellforcure: Contact Details and Business Profile - RocketReach
CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE …See details»
CELLforCURE
CELLforCURE by Seqens is currently one of the very few companies worldwide experienced with manufacturing cell and gene therapy drugs. With more than 10 000 m2 of building surface and …See details»
Novartis sells France CGT biz to Seqens - bioprocessintl.com
Dec 19, 2023 Seqens has acquired Novartis’ CGT CDMO CELLforCURE and its manufacturing site located in Les Ulis, about 23km from Paris. With this purchase, French contract …See details»
CELLforCURE Company Profile 2024: Valuation, …
When was CELLforCURE founded? CELLforCURE was founded in 2010. Where is CELLforCURE headquartered? CELLforCURE is headquartered in Les Ulis, France. What is the size of CELLforCURE? CELLforCURE has 311 total …See details»
CellforCure Company Profile - Office Locations, Competitors
CellforCure Summary. Company Summary. Overview. CellforCure is a pharmaceutical company specializing in cell and gene therapy drugs. It offers an industrial platform for drug …See details»
Novartis announces offer to acquire CellforCure to expand …
Dec 20, 2018 Established as a pharmaceutical company since 2013, CellforCure operates a Contract Development and Manufacturing Organization. The company obtained two Good …See details»
Company profile | CELLforCURE | My Biologics Partner
About us. CELLforCURE is currently one of the very few companies worldwide experienced with manufacturing cell and gene therapy drugs that have been administered to a large numbers of …See details»
Home - CELL & GENE
CELLforCURE by SEQENS stands as a leading EMA-authorized CDMO, dedicated to advancing Cell & Gene Therapies from concept to commercialization. CELLforCURE by SEQENS quality …See details»
Novartis To Acquire CDMO CellforCure for Cell and Gene Therapy ...
Jan 11, 2019 Novartis has made an offer to acquire CellforCure, a contract development and manufacturing organization (CDMO) producing cell and gene therapies in Europe, from LFB, a …See details»
Smart Immune and CELLforCURE by SEQENS Partner to …
Dec 3, 2024 PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and …See details»
Cellforcure - Biotechnology - Overview, Competitors, and Employees
CELLforCURE gathers all cell and gene therapies activities of the LFB group.With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE …See details»
CELLforCURE: inauguration of manufacturing facility - LFB corp
At the inauguration, a first international partnership agreement with the Canadian organization Héma-Québec will also be signed. The new manufacturing facility is located in Les Ulis …See details»
Smart Immune and CELLforCURE by SEQENS Partner to …
Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for Advanced Therapy …See details»
cellforcure - Company News
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing. Smart Immune, a clinical-stage biotechnology company, and CELL for …See details»
Smart Immune and CELLforCURE by SEQENS partner to …
Dec 3, 2024 Smart Immune and CELLforCURE by SEQENS partner to industrialize SMART101 clinical batches manufacturing. Smart Immune, a clinical-stage biotechnology company, and …See details»
Home | Cell4Cure AB
Apr 22, 2024 Cell4Cure AB, a cell therapy company for development of treatments for the inducing of immune tolerance. The proprietary technology platform is based on dendritic cells …See details»